The Company will report on these additional columns when they are at or nearing completion. Regulus and Coimolache, owner of the Tantahuatay oxide gold mine adjacent to the AntaKori project ...

The Company continues to work with Nuton to evaluate Nuton's proprietary sulphide bio-leaching technologies at the AntaKori project. The Phase One program identified that material from AntaKori was ...

Novartis announced plans to acquire Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company developing medicines targeting microRNAs, for $800 million. The all cash deal includes a ...

Explore the wonders of the Northern Hemisphere's night sky with our guide to the best celestial sights you can observe with binoculars between May and July.

The 2025 Skoda Elroq will land in September, having previously been earmarked for a July introduction. It’s a small-to-medium size electric SUV based on the same MEB architecture as the larger Enyaq – ...

SAN DIEGO (AP) — SAN DIEGO (AP) — Regulus Therapeutics Inc. (RGLS) on Thursday reported a loss of $9.6 million in its first quarter. The San Diego-based company said it had a loss of 15 cents ...

SAN DIEGO, May 8, 2025 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs ...

Pursuant to the Merger Agreement, Novartis, through an indirectly wholly owned subsidiary, will acquire Regulus for an initial payment of $7.00 per share of common stock in cash at closing ...